Imperial College London

Dr Michael G. Whitfield

Faculty of MedicineSchool of Public Health

Research Associate in Population Health and Policy
 
 
 
//

Contact

 

m.whitfield

 
 
//

Location

 

Commonwealth BuildingHammersmith Campus

//

Summary

 

Summary

Dr Michael Whitfield, PhD, MSc Epi, BSc, is a Research Associate in Population Health & Policy Theme in the National Institute of Health Research Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance. The HPRU is a partnership between Imperial College London, the UK Health Security Agency (previously PHE), Cambridge University, Warwick University and Imperial College Health Partners. The Unit was funded, along with 14 others in priority areas from immunisation to radiation hazards, to bring Universities to work in partnership with the UK Health Security Agency (previously PHE) to support excellent health protection research relevant to the needs of UK Health Security Agency (previously PHE). It commenced 01 April 2020 for a 5 year period and builds on the legacy of the previous HPRU which ran from 01 April 2014 -31 March 2020.

Publications

Journals

Singanayagam A, Hakki S, Dunning J, et al., 2022, Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study., The Lancet. Infectious Diseases, Vol:22, ISSN:1473-3099, Pages:183-195

Singanayagam A, Hakki S, Dunning J, et al., 2022, Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study, The Lancet Infectious Diseases, Vol:22, ISSN:1473-3099, Pages:183-195

Whitfield MG, Engelthaler DM, Allender C, et al., 2022, Comparative Performance of Genomic Methods for the Detection of Pyrazinamide Resistance and Heteroresistance in Mycobacterium tuberculosis, Journal of Clinical Microbiology, Vol:60, ISSN:0095-1137

Chisompola NK, Streicher EM, Dippenaar A, et al., 2021, Drug resistant tuberculosis cases from the Copperbelt province and Northern regions of Zambia: Genetic diversity, demographic and clinical characteristics, Tuberculosis, Vol:130, ISSN:1472-9792

Riviere E, Whitfield MG, Nelen J, et al., 2020, Identifying isoniazid resistance markers to guide inclusion of high-dose isoniazid in tuberculosis treatment regimens, Clinical Microbiology and Infection, Vol:26, ISSN:1198-743X, Pages:1332-1337

More Publications